Validation of Hemorrhoidal Bleeding Score

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03060616

Enrollment

130

Registered

2017-02-23

Start date

2016-09-01

Completion date

2018-03-15

Last updated

2023-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid Bleeding

Brief summary

The principal manifestation of hemorrhoidal disease is bleeding; however the severity evaluation is today based on prolapsus (Goligher classification) and bleeding factor is not included. Even if there was some rare score including bleeding in literature , none of them were validated. The aim of the study is first validation of bleeding score .

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age\>18 years * consulting for hemorroidal bleeding * accept to participate

Exclusion criteria

* paraplegic or hemiplegic patient * Misunderstanding of the French language

Design outcomes

Primary

Measure	Time frame
assessment of bleeding score	1 day

Countries

France

Outcome results